Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
12.91
-0.57 (-4.23%)
At close: Nov 2, 2026, 4:00 PM EST
12.91
0.00 (0.00%)
After-hours: Nov 2, 2026, 4:15 PM EST
Crescent Biopharma Market Cap
Crescent Biopharma has a market cap or net worth of $552.56 million as of November 2, 2026. It is the 13,282nd most valuable company in the world and the 2,635th biggest in the United States. Its market cap has increased by 121.68% in one year.
Market Cap
552.56M
Enterprise Value
382.41M
1-Year Change
121.68%
Global Rank
Country Rank
#2,635 United States
Category
ChartMarket Cap Chart
Since June 16, 2025, Crescent Biopharma's market cap has increased from $308.79M to $552.56M, an increase of 78.95%. That is a compound annual growth rate of 52.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 552.56M | 138.32% |
| Dec 31, 2025 | 231.86M | -24.91% |
| Jun 16, 2025 | 308.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zevra Therapeutics | 610.47M |
| Bicara Therapeutics | 604.16M |
| Nuvectis Pharma | 602.11M |
| DBV Technologies | 596.41M |
| Climb Bio | 588.72M |
| Geron | 574.63M |
| MiMedx Group | 566.19M |
| Shattuck Labs | 558.02M |